Resumen

QUINTERO GARZOLA, GABRIEL CONRADO. Review: Does Gabapentin Relieve Opioid, Cannabis and Methamphetamine Addictions?. Rev. colomb. psicol. [online]. 2020, vol.29, n.1, pp.143-161. ISSN 0121-5469.  https://doi.org/10.15446/rcp.v29n1.75930.

The study reviews the suitability of using Gabapentin for treating opioid, cannabis and methamphetamine use disorders. This revision consists of 61 biographical references based on a PubMed database search (January of 1983-May of 2018).

Gabapentin displayed respectively 50% and 66.7% of success for treating methamphetamine dependence and opioid withdrawal symptoms. Furthermore, a few research studies have reported Gabapentin's efficacy for alleviating cannabis dependence (two studies), and cannabis withdrawal symptoms (one study). Similarly, a single study reported Gabapentin reduction of opioid consumption during the detoxification process.

Based on the revision, we can conclude that: (a) Gabapentin is useful for treating opioid withdrawal symptoms, (b) additional studies are necessary for elucidating the effectiveness of Gabapentin for treating methamphetamine dependence, cannabis dependence and its withdrawal symptoms, and (c) more studies are necessary to confirm the efficacy of Gabapentin in reducing opioid consumption during detoxification.

Palabras clave : cannabis; gabapentin; methamphetamine; opioids; treatment.

        · resumen en Español | Portugués     · texto en Inglés     · Inglés ( pdf )